Manmohan Undergoes Surgical Operation At AIIMS

New Delhi: For benign enlargement of the prostate gland, Prime Minister Dr. Manmohan Singh today went through a surgical operation at the All India Institute of Medical Sciences (AIIMS).

Sanjaya Baru, Manmohan’s Media Adviser stated that the operation took place to treat benign prostatic dysplasia of the prostate gland.

“The Prime Minister was recovering and has had a stable post operative course,” Mr. Baru added.

For the next two days, Mr. Singh will stay at hospital, and it is likely that he will go back home by Monday morning.

ZTE Looking For Indian Mate For R&D

Shenzhen (China): ZTE is making exploratory survey for Indian partners in order to start research and development in broadband and internet protocol TV (IPTV) products.

Two ASI Officials Suspended Over Ram Setu Controversy

New Delhi: Two functionaries of Archaeological Survey of India (ASI) have been suspended over Ram Setu affidavit controversy.

One of the suspended officials was the director administration whereas the other was of the grade of assistant director.

Both were accountable for the drafting of the affidavit with the divisive citations to Ram that resulted to a storm of protestations.

Another Case Of Lady Teacher Sexually Harassing Girl Student

After a controversial false TV sting operation that kicked up public fury in the capital over a fortnight ago, one more sex case came up Friday, in which a woman teacher has been charged with sexua

Household Paints Contain Alarming Levels Of Lead – A Study Reports

New Delhi: Household paint samples taken from Delhi and Mumbai markets, are tested positive for presence of heavy metals’ high levels.

On Wednesday, a non-government organization “Toxics Link” released the study: “A Brush with Toxics: An Investigation on Lead in Household Paints in India.”

The study claims to have found high levels of lead in household paint samples. The samples were tested in as Indian laboratory as well as in New York Laboratory.

Dr Reddy's Gets Final FDA Nod For Ranitidine 150mg Tabs

New Delhi: Dr Reddy’s Laboratories (DRL) has received final approval for its Abbreviated New Drug Application (ANDA) for Ranitidine 150mg pill by the US Food and Drug Administration (FDA)

DRL is the only generic maker to get FDA authorization for this Abbreviated New Drug Application (ANDA) product accompanying the expiry of innovator's patents.

According to a statement, the company will distribute the 150 mg potency in blister counts of 8 and 24’s plus bottles of 50, 65 and 95 counts.